Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Oxford Lane Capital Corp (OXLC) Price & Performance

Dolby Laboratories, Inc.Trade
Oxford Lane Capital CorpTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Oxford Lane Capital Corp — how do they compare? Dolby Laboratories, Inc. trades at $60.91 (market cap $5.82B), while Oxford Lane Capital Corp trades at $9.49 (market cap $905.21M). The key difference: Dolby Laboratories, Inc. is far larger — about 6.4× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays the higher dividend (25.89%). Which is the better fit depends on your goals.

DLBOXLC
Market Cap
$5.82B$905.21M
Sector
IndustrialsFinancials
52-Week High
$75.62$18.75
52-Week Low
$48.51$8.15
Enterprise Value
$5.19B
Dividend Yield
2.32%25.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

Dolby Laboratories (DLB) trades at $61.77, up 1.4% today, with a bullish technical trend and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, including Q2 2026 EPS of $0.69 versus $0.67 expected. Revenue remains stable around $1.3 billion annually, with robust gross margins of 87.61%. Recent news highlights growth in Dolby Atmos and automotive licensing, though near-term revenue volatility persists.

DLB offers a compelling valuation with a P/E of 26.29 below the analyst target of $87.50, implying significant upside. Key risks include licensing deal timing and competitive pressures in audio-video tech. Institutional sentiment is positive, with 47% of analysts rating it a Buy, but investors should monitor execution on Q4 growth guidance.

Oxford Lane Capital Corp

OXLC trades at $9.20, up 0.44% on the day, with a bullish technical signal from moving averages but a neutral reading from oscillators. The stock's valuation shows a low price-to-book ratio of 0.88, yet profitability metrics are deeply negative with an ROE of -39.16%. Recent earnings have consistently missed expectations, and the company has declared a series of $0.20 dividends through 2026. Cash flow from operations was negative $703.80M in 2025, offset by financing activities.

The outlook is clouded by severe fundamental deterioration, including a projected revenue collapse and net loss for 2026. While the high dividend yield and discounted P/B may attract some investors, the risks from unsustainable distributions, declining net asset value, and negative returns on equity warrant extreme caution. Analyst sentiment is mixed, reflecting the stock's high-risk, high-yield profile.

Returns comparison

Trailing returns across standard periods

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB

About Oxford Lane Capital Corp

Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.

Read more on OXLC